WERN reported in line with its pre-report range and $0.01 below Cons. Rev., EBIT and EPS declined 1%, 17% and 15% y/y, each significantly worse than +1%, +9% and +11% last qtr. Relative to our reduced expectations, rev. was even worse but margins were slightly better. We are maintaining our 4Q EPS of $0.35 (vs. Cons of $0.37), but lowering our C13-C14 EPS to $1.55 and $1.75 vs. Cons. of $1.63 and $1.84. While near-term trends remain weak and WERN will likely be challenged to grow EPS the next several qtrs., we expect y/y EPS declines will start moderating in 4Q and believe TL pricing and demand can quickly firm into some inventory restocking which mgmt still expects in Nov. We also expect about a $40M ($0.50/shr or 2%) special dividend in 4Q. Based on our lower EPS, we are lowering our year-end C13 target price to $28.